Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression

NCT02675556 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Difficulty in recruitment and funding.

Conditions

Treatment Resistant Depression

Interventions

DRUG: Allo-hMSCs
DRUG: Placebo

Sponsor

Joshua M Hare